StonvexLoading…
StonvexStonvexStonvexCore line items from CSW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $773.59M | $540.60M | $263.65M | $878.30M |
Operating Income | $128.99M | $111.66M | $54.88M | $181.25M |
Net Income | $91.84M | $40.66M | $40.92M | $136.65M |
EPS (Diluted) | $5.47 | $4.84 | $2.43 | $8.38 |
Total Assets | $2.29B | $1.52B | $1.54B | $1.38B |
Total Liabilities | $1.20B | $369.40M | $405.66M | $286.63M |
Cash & Equivalents | $40.24M | $31.47M | $37.99M | $225.84M |
Free Cash Flow OCF − CapEx | $139.21M | $116.48M | $57.74M | $152.10M |
Shares Outstanding | 16.78M | 16.85M | 16.86M | 16.31M |